TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Sept. 30 psychiatry roundup highlighted a new VA policy requiring younger veterans to sign consent forms and discuss antidepressant risks and benefits before receiving a prescription. It also reported a randomized trial of an investigational app for schizophrenia and a small pilot study linking reduced ultraprocessed food intake with lower depression and anxiety scores. The reports do not establish that the app or diet change is effective for everyone.
A new Veterans Affairs policy will require younger veterans to sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription, according to a Sept. 30 psychiatry news roundup citing The New York Times. The roundup also highlighted a randomized trial of an investigational smartphone app for schizophrenia and a small pilot study of diet changes in people with major depressive disorder.
The VA policy is the clearest practice change in the reports: before prescribing antidepressants to younger veterans, clinicians will need to record a discussion of potential risks and benefits and obtain a signed consent form. The source summary does not give the policy’s effective date, age threshold, or the specific risks that must be covered. It also does not describe how the requirement will be applied in urgent situations or in ongoing treatment.
The schizophrenia finding came from a randomized trial reported in JAMA Network Open. The investigational app reduced the severity of negative symptoms, according to the roundup. Negative symptoms can include reduced motivation or social engagement, but the supplied report does not identify the app’s features, trial size, length, effect size, or whether the change persisted after the study. The result concerns a research-stage app, not an established treatment recommendation.
A separate small pilot crossover trial, also reported in JAMA Psychiatry, found that patients with major depressive disorder had lower depression and anxiety scores when they reduced ultraprocessed foods in their diets. The source does not provide the number of participants, the amount or duration of dietary change, or the size of the score reductions. The finding is an association observed during a pilot study and does not show that diet changes can replace clinical care.
Consent and Early Research Findings
The VA rule puts documented discussion and signed consent at the center of antidepressant prescribing for the younger veterans covered by the policy. That may affect how clinicians explain treatment and record decisions, but the source material does not specify the policy’s age range or operational details. It is not possible from the report to say how many veterans will be affected or whether the requirement changes which medications clinicians may prescribe.
The app and diet results matter as early research signals in areas where patients and clinicians are seeking additional options. A randomized design can test an intervention under defined study conditions, while a pilot crossover study can help guide larger research. Neither summary supplies enough information to judge the size or durability of the reported effects. Readers should not treat either finding as proof of a broadly effective intervention.
Taken together, the items show different kinds of developments: a policy requirement, a clinical trial result and preliminary dietary research. Keeping those categories distinct helps readers understand what is already changing in care and what remains under investigation.
Popular right now
Breville Bambino Espresso Machine, Brushed Stainless Steel (BES450BSS)
Vitamix 5200 Professional-Grade Blender, 64 oz. Container, Black
Dyson V8 Cyclone Cordless Vacuum
As an affiliate, we earn on qualifying purchases.
Three Different Kinds of Evidence
The source is a short psychiatry news roundup published September 30, 2026, rather than a single study or a detailed VA policy notice. It links to separate reporting and research, including The New York Times for the VA policy and JAMA Network Open and JAMA Psychiatry for the app and diet findings. The roundup provides brief descriptions, not full methods or policy documents.
That format limits what can be established. The VA item describes a planned requirement, while the app item summarizes a randomized trial and the diet item summarizes a small pilot crossover trial. Those forms of evidence answer different questions: a policy sets a process, a randomized trial tests an intervention, and pilot work can indicate whether further study may be useful. The reports do not establish that the research findings have changed standard treatment.
“An investigational smartphone app reduced the severity of negative symptoms in schizophrenia.”
— The Sept. 30 MedpageToday roundup, summarizing a randomized trial reported in JAMA Network Open
Policy and Trial Details Missing
Key details are absent from the roundup. For the VA policy, the covered age range, start date, exceptions and documentation process are not provided. The full policy or VA guidance would be needed to clarify how the requirement applies to individual prescribing decisions.
For the app trial, the report does not name the app or provide the number and characteristics of participants, the comparison group, symptom-score changes or longer-term outcomes. It is also unclear whether the tool is available outside the research setting. For the diet study, the participant count, dietary instructions, study duration and size of the score changes are not stated. The roundup therefore cannot establish how clinically meaningful or generalizable either result is.
Awaiting Full Policy and Studies
The next useful information will be the VA’s full policy guidance, including its effective date, age definition and exceptions. That would show how the consent and documentation requirement is expected to work in routine care.
For the schizophrenia app and diet intervention, fuller study reports can clarify methods, effect sizes, limitations and follow-up. Further research would be needed to determine whether the reported changes last and apply to broader groups. Until those details are available, the roundup supports describing the results as promising or preliminary only where the source supports that characterization—not as established treatment guidance.
Key Questions
What will the new VA antidepressant policy require?
According to the Sept. 30 roundup, younger veterans will need to sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription. The report does not specify the age range or effective date.
Is the schizophrenia app an approved treatment?
The roundup describes it as an investigational app studied in a randomized trial. It does not say that the app is approved, commercially available or part of standard treatment.
Does the diet study prove ultraprocessed foods cause depression?
No. The report describes a small pilot crossover trial in which lower depression and anxiety scores were seen when participants reduced ultraprocessed foods. The summary does not establish a lasting effect or show that diet changes can replace professional care.
What details are still unknown?
The roundup does not give the VA policy’s precise scope or start date, or key methods and effect sizes for either research study. Those details are needed to understand who is affected and how strong the findings are.
Source: rss
